- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03890549
Validation of Downloadable Mobile Snore Applications by Polysomnography (PSG)
March 24, 2019 updated by: Chang Gung Memorial Hospital
Validation of Downloadable Mobile Snore Applications by Polysomnography
The aim of this study is to validate the downloadable mobile snore applications by polysomnography.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Obstructive sleep apnea(OSA) is characterized by multiple episodes of upper airway collapse during sleep and considered as a major health issue worldwide due to comorbidity with obesity, hypertension, diabetes and more advanced cardiovascular diseases.
The noisy sounds of snoring caused by OSA bother bed partner sleepless and lead to long-term health problems.
Mobile snore applications are convenient and accessible for patients to monitor the progress of OSA by themselves, but there are no reliable PSG-validated applications.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: YUAN-CHIEH YEH, Doctor
- Phone Number: 2127 24313131
- Email: b9005030@gmail.com
Study Contact Backup
- Name: YI-HSIEN SHIAO, Doctor
- Phone Number: 2127 24313131
- Email: vincentking44@gmail.com
Study Locations
-
-
-
Keelung, Taiwan, 20401
- Keelung Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients diagnosed as obstructive sleep apnea no matter disease severity.
Description
Inclusion Criteria:
- Willing to sign inform consent with aged more than 20 years old
- Mild to moderate OSA, AHI (apnea-hypopnea index) < 30
Exclusion Criteria:
- Significant lung disease
- Skeletal facial framework problems
- Central apnea
- Receiving acupuncture in recent 2 weeks
- Taking hypnotic drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
obstructive sleep apnea group
The patients were diagnosed by thoracic and ENT (Eye-Nose-Throat) specialist through polysomnography.
|
The investigators selected 3 appropriate downloadable smart phone applications for snoring recording and make validation with the golden standard of polysomnography.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
snore time
Time Frame: through study completion during sleep, each sleep cycle about 6-8 hours
|
snoring time during sleep accessed by PSG and smart phone applications
|
through study completion during sleep, each sleep cycle about 6-8 hours
|
snore counts
Time Frame: through study completion during sleep, each sleep cycle about 6-8 hours
|
snoring counts during sleep accessed by PSG and smart phone applications
|
through study completion during sleep, each sleep cycle about 6-8 hours
|
snore sound
Time Frame: through study completion during sleep, each sleep cycle about 6-8 hours
|
snoring sound during sleep accessed by PSG and smart phone applications
|
through study completion during sleep, each sleep cycle about 6-8 hours
|
sleep time
Time Frame: through study completion during sleep, each sleep cycle about 6-8 hours
|
total sleep time accessed by PSG and smart phone applications
|
through study completion during sleep, each sleep cycle about 6-8 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2019
Primary Completion (Anticipated)
August 31, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
March 20, 2019
First Submitted That Met QC Criteria
March 24, 2019
First Posted (Actual)
March 26, 2019
Study Record Updates
Last Update Posted (Actual)
March 26, 2019
Last Update Submitted That Met QC Criteria
March 24, 2019
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201801799B0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
- There will be a research number representing the identity. This number will not display the name, identification number, and address.
- For the results and diagnosis of the visit, the research host will maintain a confidential attitude and carefully maintain the privacy. If research results are published, the identity will remain confidential.
- Please also understand that if the participant signs the consent form, the participant agrees that the visit record can be directly reviewed by the monitor, auditor, research ethics committee and the competent authority to ensure that the research process and data comply with relevant laws and regulations. These people also promise not to violate the confidentiality of your identity.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Snoring
-
Merz Pharmaceuticals GmbHTerminatedHabitual SnoringGermany
-
Johns Hopkins UniversityWithdrawn
-
Washington University School of MedicineRecruiting
-
Norton HealthcareDelta Dental FoundationRecruiting
-
VMS Medical Products, IncTerminated
-
Zelegent, Inc.CompletedSnoringUnited States
-
Brigham and Women's HospitalCompleted
Clinical Trials on SnoreLab (smart phone application for snoring recording)
-
Yeditepe UniversityUnknownFoot Diseases | Plantar Fascitis | Achilles Tendinopathy | Feet Pes Planus (Flatfoot) | Feet Pes CavusTurkey
-
Asthma Research Group Windsor-Essex IncUniversity Health Network, TorontoActive, not recruiting
-
Karolinska InstitutetCompletedFlexor Digitorum Profundus InjurySweden
-
University of Michigan Rogel Cancer CenterCompleted
-
Natalie GarrattInnovate UK; Gendius LtdCompleted
-
Dasman Diabetes InstituteKuwait Foundation for the Advancement of SciencesRecruitingDiabetic Foot | Diabetic Foot UlcerKuwait
-
Maastricht University Medical CenterCompletedColorectal CancerNetherlands
-
Adiyaman University Research HospitalCompleted
-
Yonsei UniversityCompletedPancreatic CancerKorea, Republic of
-
Northwestern UniversityNational Institutes of Health (NIH); Vibrent HealthWithdrawn